GRAFT VERSUS HOST DISEASE (GVHD)
Clinical trials for GRAFT VERSUS HOST DISEASE (GVHD) explained in plain language.
Never miss a new study
Get alerted when new GRAFT VERSUS HOST DISEASE (GVHD) trials appear
Sign up with your email to follow new studies for GRAFT VERSUS HOST DISEASE (GVHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fish oil infusions tested to tame transplant complication
Disease control ENROLLING_BY_INVITATIONThis study tests whether daily intravenous omega-3 fatty acids (fish oil) can reduce the risk and severity of acute graft-versus-host disease (aGVHD) in 30 adults receiving a stem cell transplant. Participants get omega-3 infusions from before transplant until about 35 days after…
Matched conditions: GRAFT VERSUS HOST DISEASE (GVHD)
Phase: PHASE1, PHASE2 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Withdrawn trial sought to protect gut cells in GVHD patients
Disease control TerminatedThis early-phase trial aimed to test whether adding the drug 5-azacytidine (AZA) to standard steroid treatment could protect gut stem cells in patients with gastrointestinal graft-versus-host disease (GVHD), a serious complication after a donor stem cell transplant. The study pla…
Matched conditions: GRAFT VERSUS HOST DISEASE (GVHD)
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC